Jade Biosciences (JBIO) Assets Average (2021 - 2026)

Jade Biosciences (JBIO) has 6 years of Assets Average data on file, last reported at $334.6 million in Q1 2026.

• Quarterly Assets Average rose 345.16% year-over-year to $334.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $334.6 million (up 345.16% YoY) and the FY2025 annual result came in at $211.3 million, up 111.06% from the prior year.
• Assets Average advanced to $334.6 million in Q1 2026, from $276.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $334.6 million in Q1 2026 to a low of $75.2 million in Q1 2025.
• A 5-year average of $155.1 million and a median of $141.5 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2024 — Assets Average sank 38.96% — and 2026, when it jumped 345.16%.
• Tracing JBIO's Assets Average over 5 years: stood at $141.5 million in 2022, then decreased by 5.18% to $134.1 million in 2023, then slumped by 38.96% to $81.9 million in 2024, then soared by 237.22% to $276.1 million in 2025, then rose by 21.18% to $334.6 million in 2026.
• The last three Assets Average figures came in at $334.6 million (Q1 2026), $276.1 million (Q4 2025), and $213.2 million (Q3 2025), per Business Quant data.